Taking your genes in hand
By The Economist,
The Economist
| 12. 06. 2007
Personal genetic testing is advancing rapidly. But beware of overselling
GENETIC testing promises a lot. In particular, it promises to tell people things ranging from their risks of developing ailments as diverse as heart disease, cancer and autism to how much coffee they can safely drink. It also promises a lucrative market for those doing the testing. Single-gene tests, such as those for particular forms of genes that predispose people to breast cancer, have been available for a while. This year, however, has seen the arrival of commercial versions of techniques that can sample a person's entire genetic make-up, and do so in a way that will enable him to benefit from future discoveries as well as existing knowledge.
In many cases, knowing the risk will also allow (and might, indeed, encourage) someone to modify his behaviour to avoid a disease he is at risk of—or, failing that, to mitigate its consequences. Nevertheless, concerns are being raised about the accuracy of some tests now on the market, and also their usefulness when the results are supplied direct to consumers, rather...
Related Articles
Public domain portrait of James D. Watson by Cold Spring Harbor Laboratory
and the National Human Genome Research Institute on Wikimedia Commons
James Watson, a scientist famous for ground-breaking work on DNA and notorious for expressing his antediluvian opinions, died on November 6, at the age of 97. Watson’s scientific eminence was primarily based on the 1953 discovery of the helical structure of DNA, for which he, Francis Crick and Maurice Wilkins shared the 1962 Nobel Prize in Physiology or...
By Megan Molteni and Anil Oza, STAT | 10.07.2025
For two years, a panel of scientific experts, clinicians, and patient advocates had been hammering out ways to increase community engagement in National Institutes of Health-funded science. When they presented their road map to the NIH Director Jay Bhattacharya last...
Paula Amato & Shoukhrat Mitalipov
[OHSU News/Christine Torres Hicks]
On September 30th, a team of 21 scientists from Oregon Health & Science University (OHSU) published a significant paper in Nature Communications, with a scientifically accurate but, to many, somewhat abstruse headline:
Induction of experimental cell division to generate cells with reduced chromosome ploidy
The lead authors were Shoukhrat Mitalipov, recently described here as “a push-the-envelope biologist,” and his long-term colleague Paula Amato. (Recall that in July the pair had co-published with...
By Pam Belluck, The New York Times | 10.17.2025
Before dawn on a March morning, Doug Whitney walked into a medical center 2,000 miles from home, about to transform from a mild-mannered, bespectacled retiree into a superhuman research subject.
First, a doctor inserted a needle into his back to...
